Econ Financial Services Corp Acquires Shares of 38,284 GE HealthCare Technologies Inc. $GEHC

Econ Financial Services Corp bought a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 38,284 shares of the company’s stock, valued at approximately $2,725,000.

Several other institutional investors have also made changes to their positions in the company. Auto Owners Insurance Co lifted its position in shares of GE HealthCare Technologies by 9,525.4% in the 4th quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company’s stock valued at $278,725,000 after acquiring an additional 33,629,559 shares in the last quarter. Norges Bank purchased a new position in GE HealthCare Technologies during the 4th quarter worth approximately $596,024,000. Barrow Hanley Mewhinney & Strauss LLC acquired a new stake in GE HealthCare Technologies during the 4th quarter valued at $533,655,000. Capital Research Global Investors raised its stake in GE HealthCare Technologies by 25.0% during the 3rd quarter. Capital Research Global Investors now owns 24,972,556 shares of the company’s stock valued at $1,875,400,000 after purchasing an additional 4,998,154 shares during the period. Finally, Cynosure Group LLC boosted its position in shares of GE HealthCare Technologies by 21,045.4% in the fourth quarter. Cynosure Group LLC now owns 4,365,462 shares of the company’s stock worth $358,055,000 after buying an additional 4,344,817 shares during the period. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Price Performance

Shares of GEHC opened at $65.76 on Friday. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.95 and a current ratio of 1.22. The firm has a market cap of $29.91 billion, a PE ratio of 15.73, a PEG ratio of 1.77 and a beta of 0.74. The firm’s 50 day moving average price is $64.51 and its 200 day moving average price is $73.96. GE HealthCare Technologies Inc. has a twelve month low of $58.75 and a twelve month high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing the consensus estimate of $1.07 by ($0.08). GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The business had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.04 billion. During the same period in the prior year, the firm earned $1.01 earnings per share. The business’s revenue was up 7.4% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, research analysts expect that GE HealthCare Technologies Inc. will post 4.89 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on GEHC. Stifel Nicolaus set a $80.00 price target on GE HealthCare Technologies in a research report on Wednesday, April 29th. Wall Street Zen cut shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a report on Saturday, March 21st. Jefferies Financial Group dropped their price objective on shares of GE HealthCare Technologies from $105.00 to $90.00 in a research note on Thursday, April 30th. Evercore set a $80.00 target price on shares of GE HealthCare Technologies in a research report on Thursday, April 30th. Finally, Argus dropped their price target on shares of GE HealthCare Technologies from $95.00 to $80.00 and set a “buy” rating on the stock in a research note on Tuesday, May 19th. Ten analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $80.20.

Insiders Place Their Bets

In other GE HealthCare Technologies news, Director Rodney F. Hochman acquired 1,618 shares of the firm’s stock in a transaction that occurred on Tuesday, May 12th. The stock was purchased at an average cost of $62.03 per share, for a total transaction of $100,364.54. Following the completion of the acquisition, the director owned 1,618 shares of the company’s stock, valued at approximately $100,364.54. This trade represents a ? increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Kevin Lobo bought 10,000 shares of the stock in a transaction on Friday, May 22nd. The shares were acquired at an average cost of $64.18 per share, for a total transaction of $641,800.00. Following the completion of the transaction, the director directly owned 14,363 shares of the company’s stock, valued at approximately $921,817.34. The trade was a 229.20% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have acquired 21,847 shares of company stock worth $1,361,355 in the last 90 days. 0.36% of the stock is owned by corporate insiders.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.